Premium Nahrungsergänzungsmittel | artgerecht

Epidermolysis – Causes, Symptoms and Treatment

Epidermolysis refers to the pathological detachment or blistering of the epidermis caused by mechanical stress. It most commonly occurs in rare genetic skin disorders or autoimmune conditions.

Regular tips about health Regular tips about health

Things worth knowing about "Epidermolysis"

Epidermolysis refers to the pathological detachment or blistering of the epidermis caused by mechanical stress. It most commonly occurs in rare genetic skin disorders or autoimmune conditions.

What is Epidermolysis?

Epidermolysis refers to the pathological separation or blistering of the epidermis (the outermost layer of the skin) from the underlying skin layers. Even minimal mechanical trauma, friction, or pressure can cause painful blisters, wounds, and erosions. The term is most commonly associated with the group of conditions known as epidermolysis bullosa, but it also encompasses acquired (non-genetic) forms.

Causes

The causes of epidermolysis can be divided into two main categories:

Genetic forms: In epidermolysis bullosa (EB), mutations affect genes that encode structural proteins of the skin (e.g., collagen VII, laminin, keratin). These proteins are essential for maintaining the integrity and cohesion of skin layers.
Acquired forms: In epidermolysis bullosa acquisita (EBA), the immune system produces autoantibodies against the skin's own structural proteins (particularly collagen VII), leading to blister formation.

Symptoms

The clinical presentation of epidermolysis varies widely depending on the type and severity:

Painful blistering triggered by minimal touch or friction
Erosions and open wounds on the skin and mucous membranes
Scarring and fusion of fingers or toes (in severe forms)
Involvement of the mouth, esophagus, and other mucous membranes
Increased risk of infection in affected skin areas
In severe cases: malnutrition, growth impairment, and elevated risk of squamous cell carcinoma

Diagnosis

Diagnosing epidermolysis involves several steps:

Clinical examination: Assessment of blisters, wounds, and scarring patterns
Skin biopsy with immunofluorescence: Determines the exact level of skin cleavage
Genetic testing: Identifies the underlying gene mutation in hereditary forms
Autoantibody testing: Blood tests to detect autoantibodies in the acquired form (EBA)

Treatment

There is currently no cure for the genetic forms of epidermolysis. Treatment focuses on symptom management and prevention of complications:

Wound Care and Skin Protection

Daily gentle wound care using non-adherent dressings
Protection from mechanical stress with specialized clothing and padding

Medication

Antibiotics for infected wounds
Immunosuppressants (e.g., corticosteroids, dapsone, rituximab) for the acquired form EBA
Pain management with appropriate analgesics

Emerging Therapies

Gene therapy: Clinical trials targeting the underlying gene mutation are currently underway
Cell therapy: Transplantation of genetically corrected skin cells
In 2023, the first gene therapy drug for epidermolysis bullosa was approved in the United States (beremagene geperpavec)

References

Has C, Bauer JW, Bodemer C et al. - Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. British Journal of Dermatology, 2020.
Murrell DF, Paller AS, Schwieger-Briel A - Epidermolysis bullosa: Pathogenesis and classification. In: Fitzpatrick's Dermatology, 9th edition, McGraw-Hill, 2019.
Koga H, Prost-Squarcioni C, Iwata H et al. - Epidermolysis Bullosa Acquisita: The 2019 Update. Frontiers in Medicine, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.